Hello, everyone, and how are you today? We hope you enjoyed the long weekend on this side of the pond and that you feel sufficiently refreshed. As you know, of course, the time has come to resume the routine of meetings and deadlines. What better way to prepare than to brew a cup of stimulation? We hope you will join us. Meanwhile, here are a few tidbits to help you along. Have a great day and stay in touch...
Dendreon Ends Pact With Glaxo Over Provenge Antigen (CNBC)
Roche Pays $10M To Evotec For Experimental Alzheimer's Med (Bloomberg News)
Biogen Reclaims Joint Ventures In Italy And Switzerland (Reuters)
USP Expands Quality Testing Lab In India (InPharma Technologist)
Boehringer And Lilly Delay Trajenta Launch In Germany (Pharma Times)
Death of Medicis CEO's Girlfriend Is Ruled A Suicide (Coronado Eagle & Journal)
Mom Suing Glaxo Does Not Have To Disclose Med Records (Vancouver Sun)
Glaxo R&D Chief Urges Alzheimer's Collaboration (The Financial Times)
Generic Lipitor May Be Delayed By Ranbaxy Problems (Bloomberg News)
PBMs Offer Senate Committee Ways To Cut Rx Spending (Pharma Times)
Indian Health Ministry Worries About Foreign Investment (The Hindu)
New Hampshire Allows Pharmacists To Give More Vaccinations (Bloomberg News)
Pfizer Superfund Site Breached By Floodwaters (MyCentralJersey)
EDITOR'S NOTE: Please look for updates to this post throughout the morning
sunrise pic thx to benimoto on flickr